Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care.

Safeguard Scientifics

MentorTech Ventures

Merck Global Health Innovation Fund

Cigna

Guardian Life

Hermed Capital

Hikma Ventures

Maywic Select Investments

Red & Blue Ventures

Hunt Holdings

LabCorp

Marshall Wace

Merck

Prognos Health

Prognos Health is excited to announce the launch of Prognos Oncology, giving life sciences and pharmaceutical customers unprecedented access to cancer diagnostics data. This powerful platform empowers pharmaceutical companies to achieve excellence in commercial launch planning and activation, ultimately expediting access to life-saving therapies for patients in need. Learn more here: https://bit.ly/496TuPd

To hear the details about this unique and exclusive offering, join Prog Mark Reis in partnership with the Genomic Testing Cooperative tomorrow, February 8, 2024 at 11:00am Eastern Time / 8:00am Pacific Time for a webinar. Register here to attend and receive event recording: https://bit.ly/3usLAkj 

This launch furthers our mission to unlock the power of data to improve health across complex clinical populations facing challenging and life-altering conditions.

#healthcareinnovation #rwd #healthoutcomes #realworlddata 

This Thursday! Don't miss out... 

Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today.

Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/3HMnDr8

Unable to attend? Use the form above and indicate "send me the recording" and we'll send the webinar your way in 48 hours. 

Join us with the Genomic Testing Cooperative on February 8 at 11:00am EST / 8:00am PST to discuss trends in cancer diagnostics and how Advancements in Comprehensive Genomic Profiling (CGP) and Next Generation Sequencing (NGS) are driving personalized medicine and the adoption of targeted therapies for individual patients in cancer care today.

Register here: February 8: Webinar with the Genomic Testing Cooperative https://bit.ly/48N0Xms

Mark Reis Jeffrey Owen Ahmad Charifa

mPulse is a competitor of Prognos Health in the health data analytics sector, offering solutions for patient engagement and healthcare marketing.

mPulse

Health Catalyst competes with Prognos Health in the health data analytics industry, providing data and analytics solutions for healthcare organizations.

Health Catalyst

Enlitic is a competitor of Prognos Health in the health data analytics sector, specializing in medical imaging and diagnostic solutions.

Enlitic

Plenful is a competitor of Prognos Health, offering a no-code automation platform for healthcare's manual workflows.

Plenful

HealthVerity competes with Prognos Health, providing a data management platform for the healthcare industry.

HealthVerity

Phreesia is a competitor of Prognos Health, offering patient intake and engagement solutions for healthcare organizations.

Phreesia

Prognos Health leverages clinical and analytical expertise to transform diagnostic and transactional data into insight-ready information, with a focus on unlocking the power of data to improve health.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Mar 4, 2024 6:06 AM	aa13b776
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 6:06 AM	687d5b96
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general
news basic	general	Mar 4, 2024 6:06 AM	b9f842d9
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:PROGNOSHEALTH

Prognos Health